GlobeReady is developed, a deployment-oriented platform powered by the RetiGlobe model and local feature augmentation that evaluates domain generalisability, Bayesian uncertainty quantification, out-of-distribution (OOD) detection, and feature-based case retrieval in medical imaging diagnostics.
Abstract
Artificial intelligence (AI) shows remarkable potential in medical imaging diagnostics, yet most current models require retraining when applied across different clinical settings, limiting their scalability. We developed GlobeReady, a deployment-oriented platform powered by the RetiGlobe foun- dation model and local feature augmentation. RetiGlobe was pretrained in two stages: 1) self-supervised learning using DINOv2 on 38 million synthetic ophthalmic images, and 2) contrastive learning using CLIP on 475,845 real image-text pairs spanning diverse ethnicities, imaging devices, and geographic regions worldwide. We evaluate GlobeReady on 488,448 ophthalmic images, including color fundus photographs (CFPs) and optical coherence tomography scans, from multi-centres in China, Singapore, Vietnam and the UK. Prospective testing included usability assessment with 31 ophthalmologists. Exploratory analyses evaluated domain generalisability, Bayesian uncertainty quantification, out-of-distribution (OOD) detection, and feature-based case retrieval.
A multimodal fundus disease diagnosis method based on progressive optimization of probabilistic correspondences is proposed, which achieves improved accuracy and Cohen's kappa under public benchmark settings, and demonstrates robustness under the evaluated noise perturbation and limited-data scenarios.
Lei Sun, Qing-Hua Peng, Xiaoxia Xiao et al.· Journal of imaging informati...· 0 citations
Small-scale implementation and cost-effectiveness studies are needed to determine whether improved access to ophthalmic imaging can translate into sustainable and equitable eye-care services, and minimum reporting standards are suggested to increase comparability across studies.
R. Lechtenboehmer, C. Cleland, F. Malerbi et al.· Progress in retinal and eye...· 0 citations
Recent advances in ophthalmic foundation models have accelerated the application of artificial intelligence in ophthalmology, improving disease detection, progression assessment, and treatment evaluation. These advances are supported by the increasing availability of multimodal ophthalmic imaging data, including optica...
Li-Ping Ren, Jun-Yang Huang, Z. Du et al.· IEEE journal of biomedical a...· 0 citations
Clinically useful OCT‐based AI should be implemented as clinician‐led decision support, with explicit intended use, external validation, calibration, post‐deployment monitoring, and lifecycle governance.
Stjepan Škudar· Eye & ENT Research· 0 citations
While AI supports objective, scalable, and reproducible analyses of ophthalmic imaging data, limitations in resolution, generalizability, and specificity prevent its use as an independent substitute for tissue-based diagnosis where histopathologic confirmation is required.
Jimena Tatiana Hathaway, Anna M. Stagner· Acta Pathologica, Microbiolo...· 0 citations
The literature supports AI as a developing decision-support tool that complements, rather than replaces, ophthalmic assessment, and further research should prioritise validation of AI-based tools in multi-centre settings, transparent documentation of errors and uncertainty, and prospective testing of systems intended f...
Qurat Ul Aen Naqvi, Aneeza Saeed, Ahmad Muneeb et al.· Journal of Engineering, Scie...· 0 citations
Known for his clear and elegant writing style, Bertsekas shaped fields from control and optimization to large-scale computation and artificial intelligence.